FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4681311000001108: Uromitexan 400mg tablets (Baxter Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18158701000001112 Uromitexan 400mg tablets (Baxter Healthcare Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18158801000001115 Uromitexan 400mg tablets (Baxter Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Is a Product containing precisely mesna 400 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has active ingredient Cytoprotective agent false Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has active ingredient Mesna false Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Is a Uromitexan true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has specific active ingredient Mesna true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uromitexan 400mg tablets (Baxter Healthcare Ltd) 10 tablet Is pack of False Uromitexan 400mg tablets (Baxter Healthcare Ltd) Inferred relationship Existential restriction modifier
Uromitexan 400mg tablets (Baxter Healthcare Ltd) 10 tablet Has AMP True Uromitexan 400mg tablets (Baxter Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start